A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors

NCT07897721 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
268
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer